Speech as a biomarker in ataxia:What can it tell us andhow should we use it?

6 July 2021

Click here to view webinar

Webinar delivered by Adam Vogel

6th July 3PM Paris

Educational webinars on rare neurological, neuromuscular and movement disorders jointly organized by the European Reference Networks for Rare Neurological Diseases (ERN-RND) and Neuromuscular Diseases (ERN EuroNMD) and the European Academy of Neurology (EAN). The speaker is Professor in Speech Pathology Audiology and Speech Pathology at the University of Melbourne, Australia. He leads the Centre for Neuroscience of Speech where his team works to improve speech, language and swallowing function in people with progressive and acquired neurological conditions. He is a recipient of an NHMRC Dementia Fellowship.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern